Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Berry v. Dowling et al
Case Number:
3:20-cv-01072
Court:
Nature of Suit:
Multi Party Litigation:
Derivative Litigation
Judge:
Firms
Companies
Sectors & Industries:
-
September 16, 2020
CBD Co. Can't Avoid Stock-Drop Suit, Shareholder Says
A shareholder behind a derivative suit against executives of CBD company CV Sciences has urged a California federal judge to keep the suit alive, pointing to another judge's ruling allowing a nearly identical case to go forward.
-
September 02, 2020
CBD Co. Execs Want Derivative Suit Over Patent Tossed
Executives from CBD company CV Sciences asked a California federal judge to throw out a derivative suit filed by shareholders who say the company misled them about the approval of a patent, saying the fact the patent was eventually approved means it made no misstatements.
-
June 15, 2020
CBD Co. Execs Hit With Derivative Suit Over Patent Rejection
Executives from CBD company CV Sciences are facing a shareholder derivative suit over claims they hid the fact its application for a patent on a CBD and nicotine product was denied, misleading investors who believed the company was still waiting for a decision from the U.S. Patent and Trademark Office.